Skin tightening and smoothing personal care product

Through specific proportions of κ, ι and λ carrageenan blends, the problem of predicting the characteristics of carrageenan mixtures is solved, and the effect of firming, smoothing and cooling the skin is achieved, showing carrageenan in versatility and stability in personal care.

CN118900683APending Publication Date: 2024-11-05CARGILL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202380025610.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-10-10
Filing Date
2023-03-31
Publication Date
2024-11-05

AI Technical Summary

Technical Problem

Since different forms of carrageenan have different properties, it is very difficult to predict the properties of its mixture, and it is difficult to effectively utilize its common positive properties in a commercial environment to avoid negative effects.

Method used

A specific proportion of blends of κ type, ι type and λ carrageenan are used, with specific ranges ranging from 7-12% κ type, 15-25% ι type and 60-80% λ type, accounting for the total 0.2-3% of the amount is used to prepare topical preparations to achieve the effect of firming, smoothing or cooling the skin.

Benefits of technology

Achieving the highly desired tightening and smoothing ability of the skin without being negatively affected, and showing significant cooling effects, improving the smoothness and firmness of the skin. It also provides good product stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005028560410000041
    Figure BDA0005028560410000041
  • Figure BDA0005028560410000061
    Figure BDA0005028560410000061
  • Figure BDA0005028560410000111
    Figure BDA0005028560410000111
Patent Text Reader

Abstract

The present invention relates to the production of personal care products having desirable texture and viscosity and exhibiting skin tightening, smoothing or cooling properties. The personal care products comprise specific mixtures of carrageenan to produce these desirable properties. More specifically, there is described a topical formulation comprising a carrageenan component wherein the carrageenan component comprises between 7% and 12% by weight of kappa type carrageenan; between 15 wt% and 25 wt% of iota-type carrageenan; between 60 wt% and 80 wt% of a lambda carrageenan; and wherein the carrageenan component comprises between 0.2 wt% and 3 wt% of the topical formulation.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims the benefit of U.S. Provisional Application No. 63 / 325,776 filed on March 31, 2022, U.S. Provisional Application No. 63 / 374,729 filed on September 6, 2022, and U.S. Provisional Application No. 63 / 378,887 filed on October 10, 2022, the entire contents of each of which are incorporated herein by reference. Technical Field

[0003] The present invention relates to the production of personal care products having a desired texture and viscosity and exhibiting skin firming, smoothing or cooling properties. These personal care products contain a specific mixture of carrageenans to produce these desired properties. Background Art

[0004] Carrageenan is a family of natural linear sulfated polysaccharides usually extracted from red edible seaweed. The most well-known and still most important red algae for making carrageenan is Chondrus crispus (Irish moss), which is a dark red parsley-like plant that grows attached to rocks. Carrageenan is a large, highly flexible molecule that forms a coiled-coil structure in a solution or mixture. This gives them the ability to form a variety of different gels at room temperature, and they are widely used in the food industry because of their gelling, thickening and stabilization properties, however, they have also gained attention in many other applications because of these properties. They are known to be active ingredients in many personal care applications.

[0005] There are three main commercial types of carrageenan (κ, iota, and λ), although there are other forms such as μ (mu) and ν (nu). κ forms a strong, rigid gel in the presence of cations such as sodium, potassium, and calcium, and reacts with milk proteins. It is primarily derived from Kappaphycus alvarezii. ι forms a soft gel in the presence of calcium ions. It is primarily produced by Eucheuma denticulatum. The λ form does not gel and is typically used to thicken dairy products.

[0006] The main differences that affect the properties of carrageenans (including kappa, iota and lambda carrageenans) are the number and position of sulfate groups on the repeating galactose units. Higher levels of sulfate lower the dissolution temperature of the carrageenans and produce gels of lower strength, or contribute to gel inhibition (e.g. lambda carrageenan).

[0007] All forms of carrageenan are soluble in hot water, but in cold water, only the lambda form (and the sodium salts of the other two) are soluble. Summary of the invention

[0008] Although many forms of carrageenan are known for use in a wide variety of commercial settings, each form has both positive and negative functional attributes. It would be desirable to have a formulation that could take advantage of the common positive attributes of the various forms without suffering the negative effects. However, due to the different properties of the different forms of carrageenan, it is very difficult to predict the properties of any mixture of these forms.

[0009] The present disclosure relates to the surprising discovery that specific blends of kappa, lambda and iota carrageenans possess highly desirable abilities to tighten and smooth skin.

[0010] In one aspect, the present invention discloses a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises:

[0011] a) between 7% and 12% by weight of kappa carrageenan;

[0012] b) between 15% and 25% by weight of iota carrageenan;

[0013] c) between 60% and 80% by weight of lambda carrageenan; and

[0014] The carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

[0015] Another aspect discloses a method of tightening or smoothing human skin, the method comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises:

[0016] a) between 7% and 12% by weight of kappa carrageenan;

[0017] b) between 15% and 25% by weight of iota carrageenan;

[0018] c) between 60% and 80% by weight of lambda carrageenan; and

[0019] The carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

[0020] Another aspect discloses a method of tightening human skin, the method comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises:

[0021] a) between 7% and 12% by weight of kappa carrageenan;

[0022] b) between 15% and 25% by weight of iota carrageenan;

[0023] c) between 60% and 80% by weight of lambda carrageenan; and

[0024] The carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

[0025] Another aspect discloses a method of smoothing human skin, the method comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises:

[0026] a) between 7% and 12% by weight of kappa carrageenan;

[0027] b) between 15% and 25% by weight of iota carrageenan;

[0028] c) between 60% and 80% by weight of lambda carrageenan; and

[0029] The carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

[0030] Another aspect discloses a method of cooling human skin comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises:

[0031] a) between 7% and 12% by weight of kappa carrageenan;

[0032] b) between 15% and 25% by weight of iota carrageenan;

[0033] c) between 60% and 80% by weight of lambda carrageenan; and

[0034] The carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

[0035] In another aspect, the present invention is directed to a carrageenan blend comprising:

[0036] a) between 7% and 12% by weight of kappa carrageenan;

[0037] b) between 15% and 25% by weight iota carrageenan; and

[0038] c) between 60% and 80% by weight of lambda carrageenan. DETAILED DESCRIPTION

[0039] Explanations of abbreviations and terms used in this disclosure are provided to aid in understanding and practicing the invention.

[0040] Unless specifically indicated otherwise, all ratios of a composition, blend or formulation referred to herein as "percentage" are meant as weight percent (wt %).

[0041] Unless otherwise indicated, all parameter ranges disclosed include the endpoints and all values ​​therebetween.

[0042] Representative features are listed in the following description, which may stand alone or be combined in any combination with one or more features disclosed elsewhere in the description of this specification and / or the drawings.

[0043] When used in this specification and claims, the terms "comprises" and "comprising" and variations thereof mean that the specified features, steps or integers are included. These terms should not be interpreted as excluding the presence of other features, steps or components.

[0044] Carrageenan

[0045] The basic structure of carrageenan is a linear polysaccharide composed of a repeating disaccharide sequence of β-D-galactopyranose linked via positions 1,3 (A residues) and α-D-galactopyranose linked via positions 1,4 (B residues). The regular backbone structure of the basic structure of carrageenan is disrupted by more or less orderly distribution of sulfate groups. Some galactose units have sulfate groups attached, while others are not sulfated. The three main types of carrageenan molecules (iota, kappa, and lambda) differ in (1) the type of linkage between the galactose units, and (2) the point of attachment and number of sulfate groups on each galactose unit. These apparently small differences in chemical composition and structure result in large differences in the properties of each type of molecule.

[0046]

[0047] Gelation in carrageenan is caused by helix formation, and this can only occur in repeating structures where the B residues are in a 1-C-4 conformation. Lambda carrageenan (theoretically with 3 sulfate groups per repeating unit) has two sugar residues in a 4-C-1 conformation and therefore does not form a gel. Therefore, it is known to those skilled in the art that lambda carrageenan should be avoided when gelation is a strong requirement for the end use of the formulation containing the carrageenan.

[0048] All gelling types of carrageenan, including the kappa type (theoretically having 1 sulfate group per repeating unit; the most naturally abundant type of carrageenan molecule) and the iota type (theoretically having 2 sulfate groups per repeating unit; the least naturally abundant type of carrageenan molecule), contain a 3,6-anhydro bridge on the B unit, which forces the sugar to flip from the 4-C-1 conformation to the 1-C-4 conformation and can then form a cross-linked network and a gel.

[0049] Some types of seaweed species contain relatively pure carrageenan fractions. Kappaphycus longicornis contains primarily kappa carrageenan and μ carrageenan, which can be converted to kappa carrageenan by alkali treatment. Eucheuma denticulata contains similarly high levels of iota carrageenan and some v carrageenan precursors. Other seaweeds are more mixed in their carrageenan content. Furcellaran contains a strongly gelling type of carrageenan, which is a mixture of kappa carrageenan and beta carrageenan in a ratio of about 3:2. Other seaweed types, such as Chondrus crispus and Gigartina types contain not only a mixture of kappa and lambda carrageenans, but also a type of carrageenan polymer, which is essentially a block copolymer of different carrageenan types. This makes carrageenan made from Gigartina or Chordus algae species have very different properties from carrageenan made from Eucheuma species from Southeast Asia.

[0050] Many red algae species produce different types of carrageenans during different stages of their developmental history. For example, the genus Taxodium produces primarily kappa carrageenan during its gametophyte stage and primarily lambda carrageenan during its sporophyte stage.

[0051] Carrageenan isolated from natural seaweed sources will contain long polymers substituted with different numbers of sulfate structures. Carrageenan will not be a pure type of repeating unit. Therefore, based on the degree of sulfate substitution and different bonds, the isolated carrageenan can be more or less of one "type". Those skilled in the art will understand that the genus, harvesting location and development stage of the seaweed will affect the type of carrageenan isolated. In addition, samples of carrageenan can be analyzed by methods known in the art to determine what proportion of polymer monomer residues belong to what type. (See, for example, Aguibal et al., Botanica Marina, Vol. 46, (2003), pp. 179-192; and Knutsen et al., Carbohydrate Research, 331, (2001), 101-106.)

[0052] The term "κ-form" as used herein refers to a form of carrageenan that contains greater than 80% of the monomer residues of its κ form. In some aspects, the κ-form will contain greater than 85% of the monomer residues of its κ form. In some aspects, the κ-form will contain between 80% and 95% of the monomer residues of its κ form.

[0053] As used herein, the term "iota form" refers to a form of carrageenan that contains greater than 80% of the monomer residues of its iota form. In some aspects, the iota form will contain greater than 85% of the monomer residues of its iota form. In some aspects, the iota form will contain between 80% and 95% of the monomer residues of its iota form.

[0054] The term "lambda form" as used herein refers to a form of carrageenan that contains greater than 20% of the monomer residues of its lambda form. In some aspects, the lambda form will contain greater than 24% of the monomer residues of its lambda form. In some aspects, the lambda form will contain between 15% and 30% of the monomer residues of its lambda form.

[0055] Various forms of carrageenan are commercially available from various commercial producers. For example, carrageenan for use in the present disclosure is commercially available from Cargill Corporation under the trade names (VPC 614κ type, VPC 430λ type, and VPC 508ι type). Like any natural product, carrageenan is a natural product isolated from cultured or harvested seaweed, and the exact content of any carrageenan extract will vary slightly depending on the time or season of harvest.

[0056] Table 1 - Composition of commercially available carrageenan from Cargill Corporation

[0057]

[0058] The * value in the table represents the average content of 7 or more samples. ND means that the amount of this form was not detected.

[0059] Personal care compositions

[0060] In one aspect, the present invention is the use of the carrageenan mixture disclosed herein in various personal care products. The personal care composition can be prepared by producing an aqueous phase that is primarily water and adding the carrageenan with mixing. Mixing is typically performed at an elevated temperature (approximately 75° C.) to facilitate complete incorporation. The type of mixing is not critical and typical mixing equipment used in the art can be used with the present compositions. In order to facilitate faster and more efficient mixing, medium shear equipment or high shear equipment is required.

[0061] Carrageenan can be added as a premix or separately. Additional ingredients can then be added to the formulation and the pH adjusted as needed. The mixture is cooled with or without stirring to produce the final personal care composition. The personal care composition may contain other active or inactive ingredients, wetting agents or emollients. Active ingredients are those that have a physiological effect on the skin or hair. The composition may be an emulsion containing an emollient, a colorant, an active ingredient and / or other texture improvers.

[0062] In the case where the temperature is still above the gel point, the pH can be adjusted to about 5.5 to 6.0 by adding an acid (such as citric acid). Additional salts or electrolytes are added to the mixture as preservatives and / or to manage the gelling properties of the carrageenan. The amount of salt or electrolyte can vary depending on the texture sought to be obtained. Typically, the amount of salt or electrolyte is about 0.25% to 1% of the composition. In some aspects, it is about 0.5%. The mixture can then be cooled. Typically, high shear mixing is avoided after adding salt or electrolyte and during cooling to maintain the final product texture.

[0063] One skilled in the art can vary the amount of carrageenan used in a personal care formulation to obtain a desired texture. In some aspects, the amount of carrageenan is between 0.2% and 3%. In other aspects, the amount is between 0.5% and 2%. In another aspect, the percentage of carrageenan in a personal care formulation is between 0.5% and 1.5%.

[0064] 1. Water Phase

[0065] The topical formulation may contain an aqueous phase. The aqueous phase may comprise or consist of water, in particular demineralized water; floral water, such as cornflower water; mineral water, such as Vittel water, Lucas water or La Roche Posay water; and / or spring water. In some aspects, demineralized water, floral water or a combination of both are used as the aqueous phase utilized by the present invention.

[0066] In some aspects, the amount of aqueous phase in the topical formulation can be between 50% and 99.5% by weight. In some aspects, the amount of aqueous phase in the topical formulation can be between 90% and 98% by weight. The aqueous phase can optionally contain other soluble components, such as alcohols or polyols. In some aspects, the aqueous phase can contain glycerol. In some aspects, the topical formulation contains 1% to 4% glycerol by weight.

[0067] 2. Lotion

[0068] In some aspects, the personal care formulation can be an emulsion. An emulsion can be defined as a mixture comprising two immiscible liquids, one of which is dispersed in the other in the form of droplets or beads. The dispersed liquid is called the dispersed phase, and the other liquid is called the continuous phase. In an oil-in-water emulsion, such as in the present invention, the oil is the dispersed phase or oil phase, and the water is the continuous phase or water phase.

[0069] The topical preparation may also contain an oil phase dispersed in an aqueous phase. As used herein, the term "dispersion" refers to an oil phase that forms droplets in an aqueous phase. The droplets may have any size or shape. Preferably, the droplets are uniformly distributed throughout the aqueous phase. The nature of the oil phase of the emulsion is not critical. Therefore, the oil phase may be composed of any fatty substance conventionally used in the field of cosmetics or dermatology; in particular, the oil phase may contain at least one oil, i.e., any fatty substance that is substantially or completely liquid at room temperature (20°C-25°C) or elevated temperature (40°C-70°C) and atmospheric pressure (760mmHg).

[0070] Preferred oily phases comprise at least one oil, which at least one oil may be: a hydrocarbon-based oil, i.e. an oil comprising mainly hydrogen and carbon atoms and optionally oxygen, nitrogen, sulfur and / or phosphorus atoms, for example in the form of hydroxyl or acid groups; a silicone oil, i.e. an oil comprising at least one silicon atom and preferably at least one Si—O group; a fluoro oil, i.e. an oil comprising at least one fluorine atom; a non-fluoro oil; or a mixture thereof.

[0071] The hydrocarbon-based oils may be of animal or vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 20 carbon atoms, examples of which include coconut oil, canola oil, rapeseed oil, sunflower oil; corn oil; soybean oil; cucumber oil; grape seed oil; sesame oil; hazelnut oil; apricot oil; macadamia oil; arak oil; castor oil; cocoa butter; almond oil; avocado oil; babassu oil; caprylic / capric triglycerides such as those sold by Stearineries Dubois or those sold by Dynamit Nobel under the trade names Miglyol 810, 812 and 818; jojoba seed oil, sold by Desert Whale under the trade name Jojoba Oil Golden; beta-carotene, sold by Cognis (BASF) under the trade name Betatene 30% OLV; canina fruit oil, sold by Nestle World Trade Co. under the trade name Rosehip Seed Oil; shea butter; and mixtures thereof.

[0072] The hydrocarbon-based oil may be a linear or branched hydrocarbon of mineral or synthetic origin. Alternatively, the hydrocarbon-based oil may be a synthetic ether; a synthetic ester; a fatty alcohol that is liquid at room temperature and has a branched chain containing 12 to 26 carbon atoms and / or a chain based on unsaturated carbons; a C12-C22 higher fatty acid; or a mixture thereof.

[0073] The personal care composition may also contain at least one additional ingredient. Additional ingredients may include, but are not limited to, preservatives, salts, vitamins, emulsifiers, texture improvers, nutrients, micronutrients, sugars, proteins, polysaccharides, polyols, glucose, sucrose, glycerol, sorbitol, pH adjusters, emollients, dyes, pigments, skin actives, waxes, or silicones.

[0074] Topical preparations

[0075] The ingredients provided herein are useful in making topical formulations, such as personal care products or cosmetics. The inventors have unexpectedly discovered that formulations comprising combinations of carrageenans in specific ratios have a number of desirable characteristics, as further described below.

[0076] In one aspect, the present invention is a topical formulation comprising an emulsion as described herein. As used herein, the term "topical formulation" refers to a formulation that can be applied directly to a part of the body. According to the present invention, the term "formulation" is used herein to refer to a composition of various ingredients within various weight ranges.

[0077] Formulations prepared with the ingredients described herein are suitable for use on (and can be applied to) the hair, scalp, nails and skin for delivering cosmetics or active substances to the skin or hair to provide cleansing, conditioning, moisturizing, minimizing or treating skin blemishes, reducing skin oiliness, providing fragrance to the hair or skin, etc.

[0078] "Personal care" means and includes any beauty, hygiene, cosmetic and topical care products, including but not limited to leave-on products (i.e., products that are left on the keratinous substrate after application); rinse-off products (i.e., products that are washed or rinsed off the keratinous substrate during or within minutes of application); shampoos; hair curling and hair straightening products; hair style holding and hair conditioning products; lotions and creams for the nails, hands, feet, face, scalp and / or body; hair dyes; facial and body makeup; nail care products; astringents; deodorants; antiperspirants; anti-acne agents; anti-aging agents; depilatories; colognes and perfumes; skin protection creams and lotions (such as sunscreens); skin and body cleansers; skin conditioners; skin toners; skin firming compositions; skin tanning and lightening compositions; liquid soaps; bar soaps; bath products; shaving products; and oral hygiene products (such as toothpastes, oral suspensions and oral care products).

[0079] The texture of such personal care formulations is not limited, and may be, but is not limited to, liquids, gels, sprays, emulsions (such as lotions and creams), shampoos, pomades, foams, tablets, sticks (such as lip care products), cosmetics, suppositories, and the like, any of which may be applied to the skin or hair or in the mouth, and are generally designed to remain in contact therewith until removed, such as by rinsing with water or washing with shampoo or soap. Other forms may be soft, rigid, or squeezable gels. Sprays may be non-pressurized aerosols delivered by a manually pumped finger-actuated sprayer, or may be pressurized aerosols in which chemical propellants or gas propellants are used, such as mousses, sprays, or foam-forming formulations.

[0080] The topical formulation comprising the emulsion disclosed herein may be a lotion, serum or cream. Advantageously, the serum or cream may comprise lambda, kappa and iota carrageenans in a specific ratio.

[0081] The formulations prepared using the ingredients disclosed herein have a transparent colorless or off-white color that is generally considered to be aesthetically appealing. In some cases, the formulations of the present invention may be further processed to prepare a colored final product. In such cases, the absence of color is beneficial because it will reveal the additional pigment without affecting the final color.

[0082] In addition, formulations prepared using the ingredients of the present invention have good spreadability and a pleasant residual feel on the skin. The texture and body of personal care products are improved using the ingredients of the present invention. The texture feels pleasant to the touch and to apply. In addition, the consistency allows for good product pickup. Good product pickup means that enough product can be collected on the user's fingers (i.e., not too much and not too little).

[0083] Personal care products for tightening skin can be applied by hand or by spreading the product onto the skin using a brush, swab, cotton pad (round or square) or fabric. The frequency of use can be determined by the user, and application can be once a day or multiple times a day.

[0084] In one aspect, the ingredients of the present disclosure are particularly useful in sunscreen applications. Sunscreens contain ingredients designed to block ultraviolet radiation from reaching the skin. The UV blocker can be a physical blocker such as or a chemical salt such as ZnO or TiO2, or a chemical blocker (maximum authorized levels indicated) such as butyl methoxydibenzoylmethane (5%); octocrylene (10%); titanium dioxide (25%); ethylhexyl salicylate (5%); ethylhexyl methoxycinnamate (10%); bis-ethylhexyloxyphenol methoxyphenyl triazine (10%); The emulsions of the present disclosure can be used with any type of UV blocker or mixture of UV blockers known in the art.

[0085] Blends

[0086] As used herein, the term "blend" refers to a physical mixture of two or more substances. In one aspect, the present invention includes a carrageenan blend for preparing the personal care compositions described herein. In another aspect, the present invention is directed to a carrageenan blend comprising: between 7% and 12% by weight of kappa carrageenan; between 15% and 25% by weight of iota carrageenan; and between 60% and 80% by weight of lambda carrageenan. In another aspect, between 8% and 12% by weight of kappa carrageenan; between 17% and 23% by weight of iota carrageenan; and between 65% and 75% by weight of lambda carrageenan. In another aspect, these blends are used to prepare personal care formulations or topical formulations, and such formulations can be used to tighten or smooth the skin.

[0087] Additionally, the personal care compositions and methods of the present invention can be prepared using a blend of carrageenans comprising or consisting of: between 23 wt% and 34 wt% kappa carrageenan; between 29 wt% and 37 wt% iota carrageenan; between 12 wt% and 20 wt% lambda carrageenan; between 2 wt% and 8 wt% mu carrageenan; and between 12 wt% and 19 wt% v carrageenan.

[0088] If desired, the carrageenan blend may additionally contain other dry ingredients in the final personal care composition, such as texture improvers, colorants, flavors, fragrances, etc. In one aspect, the blend further comprises a texture improver. Texture improvers can be used in the present invention, including but not limited to cellulose and its derivatives, synthetic polymers such as acrylates and carbomers, scleroglucan and xanthan gum. The texture improver can be present in any available or desired amount.

[0089] The blends can be prepared according to blending methods known in the art for dry ingredients. The blends described herein will be readily prepared using standard mixing equipment for a sufficient period of time.

[0090] In another aspect, the present invention relates to the use of a single type of carrageenan or any blend of single types of carrageenans in a personal care composition that can be used to smooth or tighten the skin. The blend can include all types of carrageenans or only two or more types of carrageenans. In another aspect, these blends are used to prepare personal care formulations or topical formulations, and such formulations can be used to tighten or smooth the skin.

[0091] Application of carrageenan to the skin has surprisingly been shown to affect the overall topography of the skin surface. Despite a long history of use in personal care compositions to change the texture and viscosity of products, such an effect on the skin has never been reported. The skin topography is affected in two different ways. First, application of the product has been shown to reduce the height of the small peaks on the skin and the depth of the fine wrinkles. Thus a smoothing effect is demonstrated, wherein the roughness of the skin is reduced. In addition, application of the product has been shown to narrow the width of the fine wrinkles in the skin, thereby tightening the skin and eliminating or reducing the visibility of these fine wrinkles. This effect may also be referred to as reducing wrinkles or reducing fine lines or reducing crow's feet around the eyes. The term tightening will encompass any of these optional descriptions or any description that embodies the concept of reducing the width of the fine wrinkles on the skin.

[0092] Example 1 :

[0093]

[0094] Step 1 : Prepare an aqueous phase of demineralized water and rose water and heat to approximately 70°C.

[0095] Step 2 : The carrageenan was added slowly while continuing to mix and after addition the solution was mixed for 5 minutes with the UltraTurrax set at 5000 rpm.

[0096] Step 3 : Glycerol was added and the mixture was stirred for 3 minutes with an UltraTurrax set at 5000 rpm.

[0097] Step 4 : Add potassium sorbate and sodium benzoate aqueous solutions and continue stirring until a homogeneous mixture is obtained. Adjust the pH to between 5.0 and 5.5 by adding 50% citric acid solution.

[0098] The resulting product is a slightly viscous gel that is still easily pumpable. It has a pleasant watery break upon application.

[0099] Example 1A :

[0100] Example 1A was produced in the same manner as Example 1, except that 2% carrageenan blend was used instead of 1% carrageenan blend.

[0101] Example 2 :

[0102] Material Amount weight % Demineralized water Appropriate amount 100 VPC 430 (λ Carrageenan) .70 VPC 508 (ιοcarrageenan) .20 VPC 614 (kappa carrageenan) .1 Aqueous Potassium Sorbate / Sodium Benzoate 0.15% / 0.30% Citric acid 50% aqueous solution pH 5.5

[0103] The product of Example 2 was prepared according to the method of Example 1 (without the addition of glycerin). The ability of this slightly viscous gel to smooth and tighten human skin was evaluated. The tightening and smoothing evaluation was performed using a Polytec TMS-500 interferometer using topography analysis. Polytec TMS 3.8 software was used to evaluate the surface micro-reliefs of skin explants 10 minutes before and after a single application (2 mg / cm2) of the composition of Example 2. The skin explants contained measurable high and low point topography as well as deeper fine wrinkles. In evaluating smoothness, a polytech instrument was used to measure the changes in the high and low points of the skin sample after the application of the test compound. In evaluating the firming effect, an instrument was used to measure the width of the fine wrinkles in the skin sample before and after the application of the test compound.

[0104] result

[0105] After applying the sample of Example 2, there was a surprising and immediate improvement in skin smoothness of 11%. In addition, the median width of fine wrinkles was reduced from 147 μm to 129 μm (11%), demonstrating a firming effect. In addition, 74% of the subjects in the sensory panel observed a firming effect. Therefore, this formula can be used as a visual eraser to visually smooth the skin and reduce fine lines.

[0106] When Example 1A was applied, a firming effect was evident after 3 hours (10% reduction in micro-wrinkle depth and 12.8% improvement in skin smoothness) and after 6 hours (6.6% reduction in micro-wrinkle depth and 8.8% improvement in skin smoothness).

[0107] The application of Example 1 and Example 1A showed improved skin firmness. Skin firmness can be measured using a commercially available device from Dynaskin. The Dynaskin will blow air into the skin perpendicular to the skin or at a 45 degree angle, which produces a reproducible and measurable deformation on the skin surface. Measurements before and after application of the test compound can assess any effects on skin firmness.

[0108] Ten minutes after applying the sample of Example 1, the firmness of the skin was improved, such that the deformation volume was reduced by 5.6% and the deformation depth was reduced by 5.9%. Ten minutes after applying the sample of Example 1A, the firmness of the skin was improved, such that the deformation volume was reduced by 10.7% and the deformation depth was reduced by 6.6%. The study was repeated for Example 1, but the measurements were taken 3 hours and 6 hours after application. At the 3 hour time point, the deformation volume was reduced by 10.7%, and the deformation depth was reduced by 9.7%. At the 6 hour time point, the deformation volume was reduced by 7.8%, and the deformation depth was reduced by 8.4%.

[0109] The study was repeated for Example 1A, with measurements taken 3 hours and 6 hours after application. At the 3 hour time point, the deformation volume was reduced by 11.9%, and the deformation depth was reduced by 7.1%. At the 6 hour time point, the deformation volume was reduced by 10%, and the deformation depth was reduced by 6.3%.

[0110] Importantly, these effects were observed using serum formulations with pleasant texture, stability, and spreadability. Using kappa carrageenan alone is a challenge. Generally, it is difficult to produce acceptable formulations using only kappa carrageenan because syneresis becomes a problem at the levels necessary to thicken the formulation. Syneresis is the shrinkage of the gel accompanied by liquid separation. In the case of kappa carrageenan, at elevated concentrations, the gel will experience syneresis over time. Therefore, using kappa carrageenan alone is disadvantageous.

[0111] In an additional aspect, the carrageenans disclosed herein have been shown to have a surprising cooling effect when applied to the skin. A clinical evaluation of the cooling effect was performed by applying the test samples to the forearms of 20 Caucasian female volunteers between the ages of 22 and 77 years old. Each individual had 4 test areas defined, two on each arm. One area was not treated and therefore remained as a control. Three samples were applied to the other area (2 μl / cm 2 ) until absorbed into the skin. The skin temperature was monitored for 15 minutes by an infrared camera. The three samples included Example 1, Example 1A, and a commercial benchmark sold on the market for cooling. The benchmark sample had a maximum skin temperature reduction of 2.4°C. Example 1A also showed a maximum temperature reduction of 2.4°C, whereas Example 1 showed a maximum temperature reduction of 2.7°C. Surprisingly, both Example 1 and Example 1A showed a longer cooling duration and greater overall cooling effect than the commercial benchmark.

[0112] stability

[0113] Stability is assessed visually by observing the stability of the personal care formulation over time. If the phases separate or begin to separate, the formulation has failed. Major pooling of oil or water droplets on the surface or a significant change in the visual color or texture of the sample will also indicate failure of the formulation. In addition, the viscosity can be rechecked, and a significant decrease (>20%) will indicate a formulation failure.

[0114] The carrageenan-containing formulations disclosed herein have good stability, with little or no decomposition or separation between phases over extended periods of time (e.g., 4 weeks, 8 weeks, or 12 weeks) when measured at room temperature and at 45° C. Thus, they can be used to prepare products that require a long shelf life (e.g., topical formulations).

Claims

1. A topical formulation comprising a carrageenan component, wherein the carrageenan component comprises: a) between 7% and 12% by weight of kappa carrageenan; b) between 15% and 25% by weight of iota carrageenan; c) between 60% and 80% by weight of lambda carrageenan; and wherein the carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

2. The topical preparation according to claim 1, comprising: a) between 8% and 12% by weight of kappa carrageenan; b) between 17% and 23% by weight iota carrageenan; and c) between 65% and 75% by weight of lambda carrageenan.

3. The topical formulation of claim 1, wherein the kappa carrageenan comprises greater than 80% kappa monomeric units; the iota carrageenan comprises greater than 80% iota monomeric units, and the lambda carrageenan comprises greater than 20% lambda monomeric units.

4. The topical formulation of claim 3, wherein the kappa carrageenan comprises between 80% and 95% kappa monomeric units; the iota carrageenan comprises between 80% and 95% iota monomeric units, and the lambda carrageenan comprises between 15% and 30% lambda monomeric units.

5. The topical preparation according to claim 1, which is a lotion, a serum or a cream.

6. The topical preparation according to claim 5, which is a sunscreen.

7. A method of tightening or smoothing human skin, the method comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises: a) between 7% and 12% by weight of kappa carrageenan; b) between 15% and 25% by weight of iota carrageenan; c) between 60% and 80% by weight of lambda carrageenan; and wherein the carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

8. The topical formulation according to claim 7, comprising: a) between 8% and 12% by weight of kappa carrageenan; b) between 17% and 23% by weight iota carrageenan; and c) between 65% and 75% by weight of lambda carrageenan.

9. The topical formulation of claim 7, wherein the kappa carrageenan comprises greater than 80% kappa monomeric units; the iota carrageenan comprises greater than 80% iota monomeric units, and the lambda carrageenan comprises greater than 20% lambda monomeric units.

10. The topical formulation of claim 9, wherein the kappa carrageenan comprises between 80% and 95% kappa monomeric units; the iota carrageenan comprises between 80% and 95% iota monomeric units, and the lambda carrageenan comprises between 15% and 30% lambda monomeric units.

11. The topical preparation according to claim 7, which is a lotion, a serum or a cream.

12. The topical preparation according to claim 11, which is a sunscreen.

13. A method of cooling human skin, the method comprising applying to the skin a topical formulation comprising a carrageenan component, wherein the carrageenan component comprises: a) between 7% and 12% by weight of kappa carrageenan; b) between 15% and 25% by weight of iota carrageenan; c) between 60% and 80% by weight of lambda carrageenan; and wherein the carrageenan component comprises between 0.2% and 3% by weight of the topical formulation.

14. The topical formulation according to claim 13, comprising: a) between 8% and 12% by weight of kappa carrageenan; b) between 17% and 23% by weight iota carrageenan; and c) between 65% and 75% by weight of lambda carrageenan.

15. The topical formulation of claim 13, wherein the kappa carrageenan comprises greater than 80% kappa monomeric units; the iota carrageenan comprises greater than 80% iota monomeric units, and the lambda carrageenan comprises greater than 20% lambda monomeric units.

16. The topical formulation of claim 15, wherein the kappa carrageenan comprises between 80% and 95% kappa monomeric units; the iota carrageenan comprises between 80% and 95% iota monomeric units, and the lambda carrageenan comprises between 15% and 30% lambda monomeric units.

17. The topical preparation according to claim 13, which is a lotion, a serum or a cream.

18. The topical formulation of claim 17 which is a sunscreen.

19. A carrageenan blend, comprising: a) between 7% and 12% by weight of kappa carrageenan; b) between 15% and 25% by weight iota carrageenan; and c) between 60% and 80% by weight of lambda carrageenan.

20. The blend of claim 19, comprising: a) between 8% and 12% by weight of kappa carrageenan; b) between 17% and 23% by weight iota carrageenan; and c) between 65% and 75% by weight of lambda carrageenan.

21. The blend of claim 19, wherein the kappa carrageenan comprises greater than 80% kappa monomer units; the iota carrageenan comprises greater than 80% iota monomer units, and the lambda carrageenan comprises greater than 20% lambda monomer units.

22. The blend of claim 19, wherein the kappa carrageenan comprises between 80% and 95% kappa monomer units; the iota carrageenan comprises between 80% and 95% iota monomer units, and the lambda carrageenan comprises between 15% and 30% lambda monomer units.